Call for Abstract
Scientific Program
4th International Conference on Applied Microbiology and Beneficial Microbes, will be organized around the theme “Scoping out Innovative research in Applied Microbiology & Future Trends of Beneficial Microbes”
Applied Microbes - 2019 is comprised of 19 tracks and 89 sessions designed to offer comprehensive sessions that address current issues in Applied Microbes - 2019.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Aquatic Animal Health
- Track 1-2Animal Biotechnology
- Track 1-3Zoonoses
\r\n
\r\n- Track 3-1Infectious disease
- Track 3-2Gastrointestinal malignancy
- Track 3-3Metabolic disorder
- Track 4-1Microorganisms in Pharmaceutical Industry
- Track 4-2Microbial Ecology and Next Gen Sequencing
- Track 4-3Microbial Biochemistry and Molecular Immunology
- Track 4-4Drug discovery, development and Molecular biology
- Track 4-5Pharmaceutical Nanotechnology
- Track 5-1Atherosclerosis
- Track 5-2Probiotics
- Track 5-3Cardiovascular diseases
- Track 5-4Dysbiosis of gut microbiota
- Track 5-5Symbiosis bacteria
- Track 5-6Inflammation
- Track 6-1Microbes in food
- Track 6-2Fermentation process
- Track 6-3Probiotics and prebiotics
- Track 6-4Microbial Agriculture Industry
- Track 6-5Fermenters and Fermentation
- Track 6-6Beneficial Microorganism
- Track 7-1Alternative Feedstocks
- Track 7-2Alternative Biofuels
- Track 7-3Improving Microbial Biofuel Production: Recent Developments
Microorganisms make good weapons and bioterrorism has been known to exist since centuries. This has most recently been highlighted by the terrorist attack using anthrax in the fall of 2001 in U.S. Although such attacks of bioterrorism are few, forensic evidence to criminally prosecute the perpetrator is necessary. To strengthen defence against bio crimes, a comprehensive technological network involving various fields needs to be developed. Microbial forensics is one such new discipline combining microbiology and forensic science. It uses advanced molecular techniques like microarray analysis and DNA fingerprinting etc. to associate the source of the causative agent with a specific individual or group by measuring variations between related strains. High quality assurance and quality control standards for microbial forensics will ensure highly reliable results that will stand up in the court of law. The more precise and refined a microbial system becomes, the more proper guidelines for investigations will be defined. An integrated approach towards developing this field of microbial forensics needs to be followed, to meet the challenges of bioterrorism more effectively.Microbial Forensics is currently in its developing stage. It will be most effective if there is sufficient basic scientific information concerning microbial genetics, evolution, physiology, and ecology. Better controls are needed to protect legitimate users and to deter criminal dissemination of dangerous microorganisms or their toxic by-products. Better information and/or access to information is required on those individuals who have access to these pathogens so threats can be deterred or effectively traced back to possible sources.
- Track 8-1Microbe Identification by classic Microbiology
- Track 8-2Nucleic acid ampilification techniques
- Track 8-3Serology
- Track 8-4Animal pathogens and agroterrorism
- Track 8-5Sample matrix analysis
- Track 8-6Biological agents
Pure Microbiology which provides a major platform of a large plethora of research and plenty of new insights into different areas of Microbiology. There are different branches of Microbiology such as, mycology, Virology, Immunology, infectious diseases, bacteriology, nematology, parasitology, etc. In against of pathogenic bacteria which can we used that is antibiotics either orally or paternally. The USA has about $66.28 billion worth of antibiotics that are manufactured annually, is expected to attain $75 billion by the end of 2018. During the period of 2006-2012, there was an annual growth of about 6-7% and is still growing gradually. The drugs and antibiotics have been on the steep rise and have been a fodder in Industries manufacturing for the growing economy as well: Global demand of antibiotics is approx. 78% with penicillin having 10%, erythromycin being 9%, tetracycline with 3%, and chloramphenicol about 1.4%.
- Track 9-1Microbial Interactions
- Track 9-2Impact of microbial ecology
- Track 9-3Parasitology, Nematology
- Track 9-4Systems Microbiology
- Track 9-5Generation Microbiology
- Track 9-6Quality Assurance Reporting and Survelliance system
- Track 9-7Gut Microbiota transplantations
\r\n
- Track 10-1Microbiota
- Track 10-2Dietary interventions
- Track 10-3Gastro intestinal tract [GIT]
- Track 10-4Gut Microbiota transplantations
- Track 10-5Metabolic disorders
- Track 11-1Dental plaque
- Track 11-2Dental caries
- Track 11-3Periodontal disease
- Track 11-4Cell-cell communication
- Track 11-5Vaccination against oral infections
- Track 11-6Role in non-oral disease
- Track 11-7Other microbiota
- Track 12-1Nanotechnology
- Track 12-2Tissue Engineering
- Track 12-3Bioinformatics
- Track 12-4Biomechanics
- Track 12-5Gene Therapy
- Track 12-6Diagnostic & Therapeutic Systems
- Track 13-1Microbiome and host pathology
- Track 13-2Reciprocal effects animal-bacterial genomics
- Track 13-3Bacterial roles animal origins
- Track 13-4Nested ecosystems
The host-pathogen interaction is defined as how microbes or viruses sustain themselves within host organisms on a molecular, cellular, organismal or population level. This term is most commonly used to refer to disease-causing microorganisms although they may not cause illness in all hosts. Because of this, the definition has been expanded to how known pathogens survive within their host, whether they cause disease or not. On the molecular and cellular level, microbes can infect the host and divide rapidly, causing disease by being there and causing a homeostatic imbalance in the body, or by secreting toxins which cause symptoms to appear. Viruses can also infect the host with virulent DNA, which can affect normal cell processes (transcription, translation, etc.), protein folding, or evading the immune response.
- Track 14-1Microbe-host interaction
- Track 14-2Viral and Microbial Interactions
- Track 14-3Microbe Host Interaction
- Track 14-4Host Bacterial Interaction
- Track 14-5Host Pathogen Environment Interaction
Paleomicrobiology – Past Human Infections' features the methods and main achievements in this emerging field of research at the intersection of microbiology and evolution, history and anthropology. New molecular approaches have already provided exciting results, such as confirmation of a single biotype of Yersinia pestis as the causative agent of historical plague pandemics, and the closer proximity of Mycobacterium tuberculosis from ancient skeletons to modern strains than to Mycobacterium bovis, shedding new light on the evolution of major human pathogens and pathogen–population relationships. Firm microbiological diagnoses also provide historians and anthropologists with new data on which to base evaluation of past epidemics.
- Track 16-1Community genomics
- Track 16-2Environmental genomics
- Track 16-3Data Analysis
- Track 16-4Genome analysis
- Track 16-5Microbial metatranscriptomics
- Track 16-6QWRAP bioinformatics analysis
- Track 16-7Meta genomics
- Track 17-1Microbe-aquifer interactions
- Track 17-2Biomineralization
- Track 17-3Environmental remediation and Bioremediation
- Track 17-4Microbial biodegradation
- Track 17-5Biogeochemistry
- Track 17-6Acid mine drainage
- Track 17-7Industrial Processes end product
- Track 18-1Microfactories-Microbial Production of Chemicals and Pharmaceuticals
- Track 18-2Biosurfactants: Purification, Mass Production, Applications
- Track 18-3Biotechnologically relevant Enzymes and Proteins
- Track 18-4Bioprocess Engineering and Systems Biology
- Track 19-1Gut health Improvement
- Track 19-2Cancer Prevention
- Track 19-3Immunomodulation
- Track 19-4Fighting allergies and respiratory and UT infections
- Track 19-5Relieving lactose intolerance